We have launched our mobile app, get it now. Call : 9354229384, 9354252518, 9999830584.  

Current Affairs

Blood cancer and COVID-19

Date: 05 June 2020 Tags: Miscellaneous

Issue

A study found that even if patients were actively having intensive treatment for blood cancer that weakened their immune system, they usually recovered from Covid-19 as long as they were otherwise fit and well.

 

Background

People with blood cancer are expected to be at higher risk of Covid-19 infection due to a weakened immune system from the cancer and the treatment they receive.

 

Details

  • The study looked at 35 adult patients with blood cancer who had tested positive for Covid-19 and monitored them for a minimum of 14 days. At the end of the observation period, 60% had recovered from Covid-19 infection.

  • The observations showed age was the most significantly associated factor with Covid-19 infection outcome, with almost all of the patients who died being aged 70 years or older at the time of Covid-19 diagnosis.

  • Patients who died also had significantly more coexisting health conditions, such as hypertension, chronic kidney disease or diabetes, than those who recovered from the virus.

  • The data showed no correlation between blood cancer treatment and outcome following COVID-19 infection, and suggest that while patients with blood cancers have poorer outcomes than the general population after Covid-19, the majority still survive.

  • This is the largest study to date to examine the clinical outcome of Covid-19 infection in patients with blood cancer, but added that the findings will need to be confirmed in large national and international registry studies.